Working… Menu

Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 (SOC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04440007
Recruitment Status : Active, not recruiting
First Posted : June 19, 2020
Last Update Posted : April 12, 2021
Information provided by (Responsible Party):
Sorrento Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 5, 2021
Estimated Study Completion Date : July 2021